Page 1245 - Small Animal Internal Medicine, 6th Edition
P. 1245

CHAPTER 71   Diagnostic Testing for Immune-Mediated Disease   1217


            cause thrombocytopenia by immune-mediated mechanisms;   and can be identified as an LE cell by visual inspection. LE
            therefore blood samples from such patients may be posi-  cells may also rarely be identified in vivo in blood, bone
  VetBooks.ir  tive for platelet-associated antibody. A flow cytometric assay   marrow, or joint fluid and, when present, are highly sugges-
                                                                 tive of SLE. The LE cell test is more sensitive to the effects of
            for platelet surface–associated IgG for both dogs and cats
            is currently available at Kansas State University. The test
                                                                 be positive in the blood of 30% to 90% of dogs with SLE but
            requires 2 mL of EDTA blood and currently costs $71.50   steroids than is the ANA titer. The test has been reported to
            plus shipping. Blood samples should be shipped overnight     may also be positive in other immune or neoplastic disor-
            on ice.                                              ders. This test is not used frequently in practice.
            ANTINUCLEAR ANTIBODY TEST                            RHEUMATOID FACTOR
            Measurement of antinuclear antibody (ANA) is useful in the   RF is antibody directed against an individual’s own IgG. The
            evaluation of dogs and cats with suspected systemic lupus   antibody is directed against sites on the Fc portion of immu-
            erythematosus (SLE). SLE should be suspected in patients   noglobulin molecules that become exposed only after anti-
            with evidence of an immune-mediated process affecting a   body binds to antigen. The test is used as one of the diagnostic
            minimum of two organ systems (see Chapter 73). Antinu-  criteria for rheumatoid arthritis; however, the utility of the
            clear antibodies are heterogenous antibodies directed against   test is limited by a lack of sensitivity and specificity. The most
            nuclear antigens. They are typically detected by immuno-  common technique for detection of RF is the Rose-Waaler
            fluorescent staining of frozen sections of rat liver or tissue   test, which uses sheep RBCs sensitized to rabbit IgG. If RF
            culture monolayers of human epithelial cell lines. Results are   is present in patient serum, agglutination occurs. The test is
            reported as a titer that is the highest dilution of patient   performed on refrigerated serum. Samples should not be
            serum that causes definitive immunofluorescent nuclear   frozen because RF activity may be destroyed. Only 40% to
            staining. Various patterns of nuclear staining (diffuse, speck-  75% of dogs with rheumatoid arthritis are positive for RF, so
            led, peripheral, and nucleolar) can be identified, but the   a negative titer does not rule out the disease. In addition, any
            clinical significance of the various staining patterns is still   disease with longstanding immune complex formation may
            under investigation in dogs and cats. Measurement of ANA   eventually cause RF, so a positive titer should not be the sole
            antibodies is sensitive for diagnosis of SLE in dogs and cats,   criterion for a diagnosis of rheumatoid arthritis.
            although ANA-negative cases of SLE do occur. In one study
            of 75 dogs with SLE, 100% had a positive ANA titer. In most   C-REACTIVE PROTEIN
            cases the ANA titer was greater than 1 : 256, and the magni-  C-reactive protein (CRP) is a molecule that is rapidly pro-
            tude of the titer correlated with disease severity. Other   duced as part of the nonspecific acute-phase response to
            studies have demonstrated lower sensitivity of the ANA for   most forms of inflammation. This production, princi-
            diagnosing SLE. The variability in diagnostic sensitivity   pally by hepatocytes, is stimulated by cytokines originat-
            probably arises from differences in stringency in the diag-  ing from the site of inflammation. CRP is a very sensitive
            nostic criteria for confirming a diagnosis of SLE and vari-  biomarker of inflammation. It increases rapidly in response
            ability among laboratories in assay sensitivity and specificity.   to inflammatory cytokines, and does not demonstrate
            Many normal animals have low positive titers for ANA, so a   diurnal or post-prandial variation. Biologically, CRP binds
            cutoff for a significant positive titer should be established for   to a variety of ligands, can bind complement proteins, and
            each individual laboratory. The cutoff titer varies depending   can activate the classical complement pathway similar to
            on the substrate and techniques used by the laboratory. Low   antibody binding.
            positive ANA titers may also occur after exposure to certain   The CRP concentration is a useful but nonspecific bio-
            drugs and in animals with chronic inflammatory or neoplas-  chemical marker of inflammation. CRP concentrations have
            tic diseases. ANAs are detected in 10% to 20% of dogs with   been shown to be increased in many inflammatory diseases
            seroreactivity to  Bartonella vinsonii, Ehrlichia canis, and   of the dog and cat including sepsis, pancreatitis, IMHA,
            Leishmaniasis infantum. Dogs with seroreactivity to multiple   inflammatory bowel disease, rickettsial diseases, chronic val-
            pathogens are more likely to be ANA positive. Chronic or   vular disease, and certain neoplasia. Thus CRP values are not
            high-dose corticosteroid treatment may decrease the ANA   specific for diagnosis of immune-mediated diseases but are
            titer.                                               a sensitive marker of inflammation that can be useful for
                                                                 monitoring treatment response.
            LUPUS ERYTHEMATOSUS TEST                               CRP is consistently increased in dogs with primary
            The lupus erythematosus (LE) test is a highly specific test for   IMHA, and CRP concentrations decrease in response to
            SLE but is rarely used clinically because it lacks sensitivity,   immune-suppressive treatment. Measurement of CRP is not
            and the ANA test is more sensitive and less time consuming.   useful for predicting outcome or survival in primary IMHA,
            LE cells are neutrophils that contain phagocytosed nuclear   and therefore it may not be any more useful than standard
            material. The test is performed in vitro. Blood collected from   hematologic monitoring in this disease. CRP concentration
            the  patient is  allowed  to clot  and  is damaged  in order  to   is used to monitor therapy in people with rheumatoid arthri-
            release free nuclei. If ANA is present it binds to nuclear mate-  tis, and so it has been investigated in dogs with immune-
            rial. The resulting complex is phagocytosed by neutrophils   mediated polyarthritis (IMPA). As would be expected, all
   1240   1241   1242   1243   1244   1245   1246   1247   1248   1249   1250